- Version 1
- Download 284
- File Size 1.71 MB
- File Count 1
- Create Date September 9, 2021
- Last Updated September 9, 2021
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
Attached Files
File | Action |
---|---|
2020.275958.DUELL new.pdf | Download |